Training and resources for patients and consumers
Training and resources for patients and consumers
Training and resources for patients and consumers
CHMP early contact with patient and healthcare professional organisations process and FAQs
Human medicines European public assessment report (EPAR): Vyvgart, efgartigimod alfa, Myasthenia Gravis, Date of authorisation: 10/08/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Riltrava Aerosphere, formoterol fumarate dihydrate,glycopyrronium,budesonide, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 06/01/2022, Revision: 3, Status: Authorised
Industry stakeholder platform meetings
Product-specific bioequivalence guidance
Pirfenidone product-specific bioequivalence guidance
Metformin product-specific bioequivalence guidance
Lurasidone product-specific bioequivalence guidance
Fampridine product-specific bioequivalence guidance